XML 62 R46.htm IDEA: XBRL DOCUMENT v3.25.4
DERIVATIVES (Tables)
12 Months Ended
Dec. 31, 2025
DERIVATIVES  
Schedule of fair values of derivative instruments on the Company's Consolidated Balance Sheets

December 31, 2025

December 31, 2024

Other

Other

Other

Other

Current

Current

Other

Other

Current

Current

Other

Other

Derivatives by hedge designation

Assets

  ​ ​ ​

Liabilities

  ​ ​ ​

Assets

  ​ ​ ​

Liabilities

  ​ ​ ​

Assets

  ​ ​ ​

Liabilities

  ​ ​ ​

Assets

  ​ ​ ​

Liabilities

Designated as hedging instruments:

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

Foreign exchange contracts

$

2,149

$

289

$

$

$

1,663

$

2,972

$

$

Net investment contracts

102

12,529

10,276

Not designated as hedging instruments:

 

 

Foreign exchange contracts

 

582

470

 

1,560

4,251

Total derivatives

$

2,833

$

13,288

$

$

$

13,499

$

7,223

$

$

Schedule of effects of undesignated derivative instruments on the Company's Consolidated Statements of Income

Year Ended December 31, 

Derivatives by hedge designation

  ​ ​ ​

Classification of (loss) gain

  ​ ​ ​

2025

  ​ ​ ​

2024

Not designated as hedges:

  ​

  ​

 

  ​

Foreign exchange contracts

Selling, general & administrative expenses

$

25,417

$

(11,198)

Schedule of effects of designated cash flow hedges on AOCI and the entity's Consolidated Statements of Income

  ​ ​ ​

December 31, 

Total (loss) gain recognized in AOCI, net of tax

  ​ ​ ​

2025

  ​ ​ ​

2024

Foreign exchange contracts

$

1,396

$

(812)

Forward starting swap agreements

16,291

18,067

Net investment contracts

(5,721)

20,403

  ​ ​ ​

  ​ ​ ​

Year Ended December 31, 

Gain (loss) recognized in the

Derivative type

  ​ ​ ​

Consolidated Statements of Income:

  ​ ​ ​

2025

  ​ ​ ​

2024

Foreign exchange contracts

 

Net Sales

$

2,349

$

(625)

 

Cost of goods sold

 

242

 

494

Forward starting swap agreements

Interest expense, net

2,755

1,394